Skip to main content
. 2018 Apr 26;143(6):1335–1347. doi: 10.1002/ijc.31536

Table 1.

General characteristics of BCL cases and matched controls

Baseline variable Cases (n = 268) Controls (n = 268) p valuea
Cohort, n (%)
EPIC‐Italy 84 (31.3) 84 (31.3)
NSHDS 184 (68.7) 184 (68.7)
Phase, n (%)
1 96 (35.8) 96 (35.8)
2 172 (64.2) 172 (64.2)
Sex, n (%)
Male 132 (49.3) 132 (49.3)
Female 136 (50.7) 136 (50.7)
Age at recruitment (years)2 53.1 (7.8) 53.1 (7.8) 0.99
Alcohol intake (g/day)2 7.05 (12.5) 8.25 (14.7) 0.32
Body mass index (kg/m2)2 26.36 (3.8) 26.53 (4.1) 0.57
Smoking Status, n (%) 0.80
Never 145 (54.1) 150 (56.0)
Former 68 (25.4) 63 (23.5)
Current 55 (20.5) 55 (20.5)
Highest educational level, n (%) 0.28
None 4 (1.5) 1 (0.4)
Primary 96 (35.8) 104 (38.8)
Technical/professional 68 (25.4) 56 (20.9)
Secondary 53 (19.8) 65 (24.3)
University/college 47 (17.5) 42 (15.7)
Physical activity (Cambridge index), n (%) 0.22
Inactive 80 (29.9) 76 (28.4)
Moderately inactive 106 (39.6) 95 (35.4)
Moderately active 68 (25.4) 74 (27.6)
Active 14 (5.2) 23 (8.6)
BCL sub‐types, n (%)3
DLBCL 44 (16.4)
FL 39 (14.6)
CLL 42 (15.6)
MM 76 (28.4)
Other subtypes 67 (25)

Abbreviations: CLL, chronic lymphocytic leukemia; DLBCL, diffuse large BCL; FL, follicular lymphoma; MM, multiple myeloma; EPIC, European Prospective Investigation into Cancer and Nutrition; and NSHDS, the Northern Sweden Health and Disease Study.

a

P values are based on t‐tests for continuous variables and χ2 tests for categorical variables. 2Mean (standard deviation). 3Number of cases for each subtype in EPIC‐Italy: DLBCL = 11, CLL = 11, FL = 20, MM = 21, others = 21, and in NSHDS: DLBCL = 33, CLL = 31, FL = 19, MM = 55, others = 46.